Disparities in Time to Treatment for Skin Cancer

Syeda Hoorulain Ahmed, Harsheen Kaur Manaise, Reed Popp, Seema Sharan, Shivam Bansal, Kulkaew Belle Sukniam, Swathi R. Raikot, Gabrielle Kowkabany, Paola Berrios Jimenez, Kyle Popp, Fatima Mubarak, Anthony George, Emmanuel Gabriel

Research output: Contribution to journalArticlepeer-review

Abstract

Background/Aim: Skin cancer is the most common cancer worldwide. This study aimed to identify factors contributing to the disparities in skin cancer treatment. Patients and Methods: Data from The National Cancer Database (NCDB) spanning 2004 to 2019 were utilized. Variables including age, sex, race, Hispanic origin, Charlson-Deyo Comorbidity (CDC) score, geographic location, insurance status, income, grade and stage of cancer, and type of treatment facility impacting the time to treatment, surgery, radiation, and chemotherapy were analyzed. Results: Trends of longer time to treatment were seen with older age, non-Hispanic white, uninsured, those with a higher CDC score, and treated at academic facilities. Additionally, annual income and clinicopathology of cancer were also significantly associated with time to treatment. Conclusion: Our findings contribute to the expanding body of evidence pointing to the influence of socioeconomic and demographic factors in treatment disparities across diverse patient populations.

Original languageEnglish
Pages (from-to)5555-5562
Number of pages8
JournalAnticancer Research
Volume43
Issue number12
DOIs
Publication statusPublished - 2023

Keywords

  • disparity
  • Skin cancer
  • treatment

Fingerprint

Dive into the research topics of 'Disparities in Time to Treatment for Skin Cancer'. Together they form a unique fingerprint.

Cite this